View the 2018 Agenda!
Join your peers to address the challenges of balancing current safety challenges with future data concerns. View more information on:Unparallelled Opportunities to hear regulatory updates real time from both multi department and international perspective
Dear Boss Letter - 2018 Pharmacovigilance Summit
Justify your attendance with our customizable Dear Boss Letter! If you prefer to receive this via email contact Stephen.Aponte@iqpc.com.
Registration Form: Pharmacovigilance 2018
Want to be part of Pharmacovigilance 2018? Access our registration form and send it back to Stephen.Aponte@iqpc.com to save your spot at the event taking place this February!
Anticipated Attendee Snapshot: 2018 Pharmacovigilance
Find out who you can expect to meet and learn from at the 2018 Pharmacovigilance Summit February 26-28, 2018 in Boston, MA in this list of past as well as expected attendee job titles and companies. If you prefer to receive this via email contact Stephen.Aponte@iqpc.com.
Registration Packet - Pharmacovigilance 2018
get a jumpstart on building your case to attend the 2018 Pharmacovigilance Summit with our Registration Packet. This resource packet includes:Anticipated Attendee SnapshotDear Boss LetterRegistration Form
Top 5 Challenges of Pharmacovigilance in 2017 and Beyond
With the rapid spread of information across the globe, increased communication across borders, increasing public expectation of safety and improved global access to drugs, the challenges associated as well as the importance of pharmacovigilance has never been greater. In this short and sweet interactive overview of the Top 5 Challenges...
SPEAKER SPOTLIGHT: A conversation with Sameer Thapar, Global Pharmacovigilance Operations & Compliance, Rutgers University
Get to know speaker Sameer Thapar, Global Pharmacovigilance Operations & Compliance, Rutgers University in this short interview where he shares how he sees PV evolving over the next 5 years, emerging trends, key challenges and more! If you prefer to receive this via email contact Stephen.Aponte@iqpc.com.
Is big pharma really on cusp of AI shake-out?
Artificial intelligence could herald a new era for drug development but, as this Pharma IQ article explains, caution remains about how revolutionary its impact will actually be.If you prefer to receive this via email contact Stephen.Aponte@iqpc.com.
Get Beyond The Silo With Big Data Analytics Infographic
In this infographic, Pharma IQ assesses the concept of data silos within the corporate world. While exploring the barriers these stubborn blocks of data provide, specialists provide their expertise on how and why the pharmaceutical industry needs to break open the data silos.If you prefer to receive this via email...
2017 Cell and Gene Therapy Heatmap - Europe The Road To Commercialisation
Over the last 12 months, the cell and gene therapy manufacturing sphere has matured vastly with more companies advancing to commercial products, especially with allogenic therapies. Now that the theory behind the therapy is catching up with the technology, the two can come together to progress towards producing commercial products....
Pharma Quantified: Industry Facts and Figures
Pharma IQ presents a few statistics gathered from the medical press on today’s drug discovery industry.If you prefer to receive this via email contact Stephen.Aponte@iqpc.com.
It's a good time to be a data scientist in the pharmaceutical industry
Data analytics is surrounded by a lot of hype, but where is the real ‘value add’ for the Pharmaceutical industry? How is the industry preparing for the future of drug development and patient engagement? Pharma IQ asked Nigel Hughes, Scientific Director at Janssen, to have a chat with us about...
Life Sciences Manufacturing and Quality: The New Path to Performance
It is no secret that Life Science manufacturers have substantial compliance challenges. Regulatory burdens are getting more intense, regularly changing, and growing in complexity. This is most keenly felt by those that are delivering products in multiple markets.Successful manufacturers will plot a journey from conformance to performance by merging the...
Top 5 Technologies Set to Transform Pharmacovigilance
The effectiveness of pharmacovigilance (PV) in Asia has been steadily increasing over recent decades thanks to the growing prevalence of e-clinical and e-health solutions. However now, in the second decade of the 21st century, we are seeing the pace of technological development shift from incremental improvements, to becoming truly transformative,...
Speaker Perspectives: Real World Data as the Cornerstone of Pharmacovigilance
This packet includes 3 articles by 2018 Pharmacovigilance speaker Ale (Maria) Vazquez-Gragg, MD, VP, Head Global Patient Safety, Intarcia Therapeutics, Inc. on the power of real world data to enable improved PCV. Download to learn more about:RWE to Build the Scientific Voice Maximizes Health Care DecisionsRWE: Predictive Analytics To Impact...
Early Automation of Data Mining at the FDA using Oracle Health Sciences Empirica Signal and Study
Since the early 1990s, the FDA has used data mining (the practice of examining large databases to generate new information) to gain a better understanding of adverse signals within clinical trial safety data. The agency has also advocated the use of data mining by the pharmaceutical industry when conducting clinical...
Pharmacovigilance in the Age of the Specialty Pharmacy
To protect patient safety in the dispensing and utilization of specialized medications, a compromise needs to be put in place between the manufacturer and the specialty pharmacy concerning the need to perform timely pharmacovigilance reporting. This article by 2018 Pharmacovigilance speaker Sameer Thapar, Assistant Professor, Drug Safety & Pharmacovigilance at...